Characterization of real‐world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center
Abstract Objectives We conducted this retrospective study to characterize the change in chronic lymphocytic leukemia (CLL) treatment patterns between 2005 and 2019, to understand the treatment sequencing across the course of the disease, and to investigate how targeted agents and prognostic testing...
Main Authors: | Juha Ranti, Katariina Perkonoja, Tommi Kauko, Heidi Loponen, Emmi I. Joensuu, Tiina M. Järvinen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.322 |
Similar Items
-
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
by: Francesco Angotzi, et al.
Published: (2024-03-01) -
Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia
by: Francesco Forconi, et al.
Published: (2022-01-01) -
Association of Cytogenetics Aberrations and <i>IGHV</i> Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting
by: Carolina Muñoz-Novas, et al.
Published: (2024-01-01) -
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
by: Nawar Maher, et al.
Published: (2023-06-01) -
Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of <i>MYD88</i> Mutations
by: Ari Ahn, et al.
Published: (2023-02-01)